| Number of cases (%) |
---|---|
Gender | Â |
Male | 40 (55.6) |
Female | 32 (44.4) |
Age (years) | Â |
≤60 | 41 (56.9) |
>60 | 31 (43.1) |
Clinical stage | Â |
I | 6 (8.4) |
II | 38 (52.8) |
III | 14 (19.4) |
IV | 14 (19.4) |
T classification | Â |
T1 | 0 (0) |
T2 | 12 (16.7) |
T3 | 41 (56.9) |
T4 | 19 (26.4) |
N classification | Â |
N0 | 45 (62.5) |
N1 | 27 (37.5) |
M classification | Â |
M0 | 58 (80.6) |
M1 | 14 (19.4) |
Pathologic differentiation | Â |
Poor | 41 (56.9) |
Moderate | 28 (38.9) |
Well | 3 (4.2) |
Expression of PAK1 | Â |
Low expression | 34 (47.2) |
High expression | 38 (52.8) |